1. Home
  2. CLLS vs LTRX Comparison

CLLS vs LTRX Comparison

Compare CLLS & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • LTRX
  • Stock Information
  • Founded
  • CLLS 1999
  • LTRX 1989
  • Country
  • CLLS France
  • LTRX United States
  • Employees
  • CLLS N/A
  • LTRX N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • LTRX Computer Communications Equipment
  • Sector
  • CLLS Health Care
  • LTRX Telecommunications
  • Exchange
  • CLLS Nasdaq
  • LTRX Nasdaq
  • Market Cap
  • CLLS 148.1M
  • LTRX 144.7M
  • IPO Year
  • CLLS 2007
  • LTRX 2000
  • Fundamental
  • Price
  • CLLS $1.53
  • LTRX $2.91
  • Analyst Decision
  • CLLS Buy
  • LTRX Strong Buy
  • Analyst Count
  • CLLS 3
  • LTRX 6
  • Target Price
  • CLLS $7.00
  • LTRX $5.83
  • AVG Volume (30 Days)
  • CLLS 114.3K
  • LTRX 464.6K
  • Earning Date
  • CLLS 11-04-2024
  • LTRX 02-06-2025
  • Dividend Yield
  • CLLS N/A
  • LTRX N/A
  • EPS Growth
  • CLLS N/A
  • LTRX N/A
  • EPS
  • CLLS N/A
  • LTRX N/A
  • Revenue
  • CLLS $36,042,000.00
  • LTRX $155,842,000.00
  • Revenue This Year
  • CLLS $387.77
  • LTRX N/A
  • Revenue Next Year
  • CLLS $11.14
  • LTRX $11.33
  • P/E Ratio
  • CLLS N/A
  • LTRX N/A
  • Revenue Growth
  • CLLS 46.96
  • LTRX 12.96
  • 52 Week Low
  • CLLS $1.41
  • LTRX $2.49
  • 52 Week High
  • CLLS $3.38
  • LTRX $4.55
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 45.06
  • LTRX 34.15
  • Support Level
  • CLLS $1.51
  • LTRX $2.88
  • Resistance Level
  • CLLS $1.62
  • LTRX $4.27
  • Average True Range (ATR)
  • CLLS 0.09
  • LTRX 0.21
  • MACD
  • CLLS 0.01
  • LTRX -0.07
  • Stochastic Oscillator
  • CLLS 29.17
  • LTRX 2.16

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.

Share on Social Networks: